Publications

1. Elmunzer BJ, Serrano J, Chak A, Edmundowicz SA, Papachristou GI, Scheiman JM, Singh VK, Varadurajulu S, Vargo JJ, Willingham FF. Rectal indomethacin alone versus indomethacin and prophylactic pancreatic stent placement for preventing pancreatitis after ERCP: study protocol for a randomized controlled trial. Trials. 2016;17(1):120.

1. Venkat VL, Shneider BL, Magee JC, Turmelle Y, Arnon R, Bezerra JA, Hertel PM, Karpen SJ, Kerkar N, Loomes KM. Total serum bilirubin predicts fat-soluble vitamin deficiency better than serum bile acids in infants with biliary atresia. Journal of pediatric gastroenterology and nutrition. 2014;59(6):702.

2. Bezerra JA, Spino C, Magee JC, Shneider BL, Rosenthal P, Wang KS, Erlichman J, Haber B, Hertel PM, Karpen SJ. Use of corticosteroids after hepatoportoenterostomy for bile drainage in infants with biliary atresia: the START randomized clinical trial. Jama. 2014;311(17):1750-9.

3. Shneider BL, Magee JC, Bezerra JA, Haber B, Karpen SJ, Raghunathan T, Rosenthal P, Schwarz K, Suchy FJ, Kerkar N. Efficacy of fat-soluble vitamin supplementation in infants with biliary atresia. Pediatrics. 2012;130(3):e607-e14.

1. Foxman B, Cronenwett AE, Spino C, Berger MB, Morgan DM. Cranberry juice capsules and urinary tract infection after surgery: results of a randomized trial. American journal of obstetrics and gynecology. 2015;213(2):194.

2. Marschall J, Piccirillo ML, Foxman B, Zhang L, Warren DK, Henderson JP. Patient characteristics but not virulence factors discriminate between asymptomatic and symptomatic E. coli bacteriuria in the hospital. BMC infectious diseases. 2013;13(1):213.

3. Marschall J, Zhang L, Foxman B, Warren DK, Henderson JP. Both host and pathogen factors predispose to Escherichia coli urinary-source bacteremia in hospitalized patients. Clinical infectious diseases. 2012;54(12):1692-8.

1. Baldwin JT, Mann DL. NHLBI's program for VAD therapy for moderately advanced heart failure: the REVIVE-IT pilot trial. Journal of cardiac failure. 2010;16(11):855-8.

2. Pagani FD, Aaronson KD, Kormos R, Mann DL, Spino C, Jeffries N, Taddei-Peters WC, Mancini DM, McNamara DM, Grady KL. The NHLBI REVIVE-IT study: Understanding its discontinuation in the context of current left ventricular assist device therapy. Elsevier; 2016.

1. Maestas MM, Brook RD, Ziemba RA, Li F, Crane RC, Klaver ZM, Bard RL, Spino CA, Adar SD, Morishita M. Reduction of personal PM2.5 exposure via indoor air filtration systems in Detroit: an intervention study. Journal of Exposure Science and Environmental Epidemiology (accepted) (2018).

1. Borello-France D, Burgio KL, Goode PS, Ye W, Weidner AC, Lukacz ES, Jelovsek J-E, Bradley CS, Schaffer J, Hsu Y. Adherence to behavioral interventions for stress incontinence: rates, barriers, and predictors. Physical therapy. 2013;93(6):757.

2. Kenton K, Barber M, Wang L, Meikle S, Hsu Y, Rahn D, Whitcomb E, Amundsen C, Bradley C, Zyczynski H. Pelvic floor symptoms improve similarly after pessary and behavioral treatment for stress incontinence. Female pelvic medicine & reconstructive surgery. 2012;18(2):118.

3. Schaffer J, Nager CW, Xiang F, Borello-France D, Bradley CS, Wu JM, Mueller E, Norton P, Paraiso MFR, Zyczynski H. Predictors of success and satisfaction of nonsurgical therapy for stress urinary incontinence. Obstetrics and gynecology. 2012;120(1):91.

1. Jelovsek JE, Chagin K, Brubaker L, Rogers RG, Richter HE, Arya L, Barber MD, Shepherd JP, Nolen TL, Norton P. A model for predicting the risk of de novo stress urinary incontinence in women undergoing pelvic organ prolapse surgery. Obstetrics and gynecology. 2014;123(2 0 1):279.

2. Gutman RE, Nygaard IE, Ye W, Rahn DD, Barber MD, Zyczynski HM, Rickey L, Nager CW, Varner RE, Kenton K. The Pelvic Floor Complication Scale: a new instrument for reconstructive pelvic surgery. American journal of obstetrics and gynecology. 2013;208(1):81. e1-. e9.

1. Grimes C, Lukacz ES, Gantz MG, Warren LK, Brubaker L, Zyczynski HM, Richter HE, Jelovsek JE, Cundiff G, Fine P. What happens to the posterior compartment and bowel symptoms after sacrocolpopexy? evaluation of 5-year outcomes from E-CARE. Female pelvic medicine & reconstructive surgery. 2014;20(5):261.

2. Nygaard I, Brubaker L, Zyczynski HM, Cundiff G, Richter H, Gantz M, Fine P, Menefee S, Ridgeway B, Visco A. Long-term outcomes following abdominal sacrocolpopexy for pelvic organ prolapse. Jama. 2013;309(19):2016-24.

1. Brubaker L, Nager CW, Richter HE, Weidner AC, Hsu Y, Wai CY, Paraiso M, Nolen TL, Wallace D, Meikle S. Effectiveness of blinding: sham suprapubic incisions in a randomized trial of retropubic midurethral sling in women undergoing vaginal prolapse surgery. American journal of obstetrics and gynecology. 2014;211(5):554. e1-. e7.

2. Wei JT, Nygaard I, Richter HE, Nager CW, Barber MD, Kenton K, Amundsen CL, Schaffer J, Meikle SF, Spino C. A midurethral sling to reduce incontinence after vaginal prolapse repair. New England Journal of Medicine. 2012;366(25):2358-67.

1. Mueller ER, Corton M, Fielding J, Spino C, Jelovsek JE, Weidner A, Zyczynski H, Menefee S, Gantz MG, Tuteja A, Richter HE, Pelvic Floor Disorders Network. Results of a Novel and Comprehensive Training Program for Standardization of 2-Dimensional Ultrasound Interpretation as a Precursor to a Multicenter Trial JJ Med Diagnosis and Image. 2016 May; 1(1): 012.

2. Richter HE, Nager CW, Burgio KL, Whitworth R, Weidner AC, Schaffer J, Zyczynski HM, Norton P, Jelovsek JE, Meikle SF, Spino C, Gantz M, Graziano S, Brubaker L, Network NPFD. Incidence and Predictors of Anal Incontinence After Obstetric Anal Sphincter Injury in Primiparous Women. Female Pelvic Med Reconstr Surg. 2015;21(4):182-9. doi: 10.1097/SPV.0000000000000160. PubMed PMID: 25679358; PMCID: PMC4481184.

1. Lukacz ES, Warren LK, Richter HE, Brubaker L, Barber MD, Norton P, Weidner AC, Nguyen JN, Gantz MG. Quality of Life and Sexual Function 2 Years After Vaginal Surgery for Prolapse. Obstetrics & Gynecology. 2016;127(6):1071-9.

2. Barber MD, Brubaker L, Burgio KL, Richter HE, Nygaard I, Weidner AC, Menefee SA, Lukacz ES, Norton P, Schaffer J. Comparison of 2 transvaginal surgical approaches and perioperative behavioral therapy for apical vaginal prolapse: the OPTIMAL randomized trial. Jama. 2014;311(10):1023-34.

3. Barber MD, Kenton K, Janz NK, Hsu Y, Dyer KY, Greer WJ, White A, Meikle S, Ye W. Validation of the activities assessment scale in women undergoing pelvic reconstructive surgery. Female pelvic medicine & reconstructive surgery. 2012;18(4):205.

4. Barber MD, Janz N, Kenton K, Hsu Y, Greer WJ, Dyer K, White A, Meikle S, Ye W. Validation of the surgical pain scales in women undergoing pelvic reconstructive surgery. Female pelvic medicine & reconstructive surgery. 2012;18(4):198.

1. Visco AG, Zyczynski H, Brubaker L, Nygaard I, Xu X, Lukacz ES, Paraiso MF, Greer J, Rahn DD, Meikle SF. Cost-Effectiveness Analysis of Anticholinergics Versus Botox for Urgency Urinary Incontinence: Results From the Anticholinergic Versus Botox Comparison Randomized Trial. Female Pelvic Medicine & Reconstructive Surgery. 2016;22(5):311-6.

2. Visco AG, Brubaker L, Jelovsek JE, Wilson TS, Norton P, Zyczynski HM, Spino C, Sirls L, Nguyen JN, Rahn DD. Adherence to oral therapy for urgency urinary incontinence: results from the Anticholinergic versus Botox Comparison (ABC) trial. Female pelvic medicine & reconstructive surgery. 2016;22(1):24-8.

3. Pearce MM, Zilliox MJ, Rosenfeld AB, Thomas-White KJ, Richter HE, Nager CW, Visco AG, Nygaard IE, Barber MD, Schaffer J. The female urinary microbiome in urgency urinary incontinence. American journal of obstetrics and gynecology. 2015;213(3):347. e1-. e11.

4. Brubaker L, Nager CW, Richter HE, Visco A, Nygaard I, Barber MD, Schaffer J, Meikle S, Wallace D, Shibata N. Urinary bacteria in adult women with urgency urinary incontinence. International urogynecology journal. 2014;25(9):1179-84.

5. Visco AG, Brubaker L, Richter HE, Nygaard I, Paraiso MFR, Menefee SA, Schaffer J, Lowder J, Khandwala S, Sirls L. Anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence. New England Journal of Medicine. 2012;367(19):1803-13.

6. Visco AG, Brubaker L, Richter HE, Nygaard I, Paraiso MF, Menefee SA, Schaffer J, Wei J, Chai T, Janz N. Anticholinergic versus botulinum toxin A comparison trial for the treatment of bothersome urge urinary incontinence: ABC trial. Contemporary clinical trials. 2012;33(1):184-96.

1. Lisabeth LD, Diex Roux AV, Escobar JD, Smith MA, Morgenstern LB. Neighborhood environment and risk of ischemic stroke. Am J Epidemiol 2007;165:279-287.

2. Brown DL, Al-Senani F, Lisabeth LD, Farnie MA, Colletti LA, Langa KM, Fendrick AM, Garcia NM, Smith MA, Morgenstern LB. Defining cause of death in stroke patients: the Brain Attack Surveillance in Corpus Christi Project. Am J Epidemiol 2007 165:591-596.

3. Gonzales NR, Brown DL, Maddox KE, Conley KM, Espinosa N, Pary JK, Karim AP, Moyé LA, Grotta JC, Morgenstern LB. Kids Identifying and Defeating Stroke (KIDS): Design of a School Based Intervention to Improve Stroke Awareness. Ethn Dis 2007: Spring;17:320-326.

4. Zahuranec DB, Brown DL, Lisabeth LD, Gonzales NR, Longwell PJ, Smith MA, Garcia N, Morgenstern LB. Early care limitations independently predict mortality after intracerebral hemorrhage. Neurology 2007;68:1651-1657.

5. Morgenstern LB, Gonzales NR, Maddox KE, Brown DL, Karim AP, Espinosa N, Moyé LA, Pary JK, Grotta JC, Lisabeth LD, Conley KM. A Randomized, controlled trial to teach middle school children to recognize stroke and call 911: The Kids Identifying and Defeating Stroke project (KIDS). Stroke 2007;38:2972-2978.

6. Majersik JJ, Smith MA, Zahuranec DB, Sánchez BN, Morgenstern LB. Population-based analysis of the impact of expanding the time window for acute stroke treatment. Stroke , Stroke 2007 38:3213-7.

7. Conley, KM, Majersik JJ, Gonzales GR, Maddox KE, Pary JK, Brown DL, Moye LA, Espinosa N, Grotta JC, Morgenstern LB. Kids identifying and defeating stroke (KIDS): Development and implementation of a multi-ethnic health education intervention to increase stroke awareness among middle school students and their parents. Health Promotion Practice , 2008 Mar 10 [Epub ahead of print].

8. Brown DL, Lisabeth LD, Chetcuti SJ, Grossman PM, Alexander T, Pappas JD, Moscucci M, Eagle KA, Garcia NM, Smith MA, Morgenstern LB. Screening for myocardial infarction and ischemic stroke: A population-based study. Neuroepidemiology 2007;29:96-100.

9. Zahuranec DB, Morgenstern LB, Garcia NM, Conley KM, Lisabeth LD, Rank GS, Smith MA, Meurer WJ, Resnicow K, Brown DL. Stroke health and risk education (SHARE) pilot project: feasibility and need for church-based stroke health promotion in a bi-ethnic community. Stroke 2008;39:1583-1585.

10. Lisabeth LD, Peyser PA, Long JC, Majerisk JJ, Smith MA, Morgenstern LB. Stroke among siblings in a bi-ethnic community. Neuroepidemiol 2008;31:33-38.

11. Lisabeth LD, Escobar JD, Dvonch JT, Sanchez BN, Majersik JJ, Brown DL, Smith MA, Morgenstern LB. Ambient air pollution and risk of ischemic stroke and TIA. Ann Neurol2008; 64: 53-59.

12. Lisabeth LD, Smith MA, Sánchez BN, Brown DL. Ethnic disparities in stroke and hypertension among women: the BASIC project. Am J Hypertens 2008; 21:778-783.

13. Eden SV, Meurer WJ, Sánchez BN, Lisabeth LD, Smith MA, Brown DL, Morgenstern LB.Gender and ethnic differences in subarachnoid hemorrhage. Neurology 2008; 2;71:731-735.

14. Meurer WJ, Sánchez BN, Smith MA, Lisabeth LD, Majersik JJ, Brown DL, Uchino K, Bonikowski FP, Mendizabal JE, Zahuranec DB, Morgenstern LB. Predicting ischaemic stroke subtype from presenting systolic blood pressure: the BASIC Project. J Intern Med2009;265:388-396.

15. Morgenstern LB, Escobar JD, Sánchez BN, Hughes R, Zuniga BG, Garcia N, Lisabeth LD. Fast food and neighborhood stroke risk. Ann Neurol 2009; 66:165-170.

16. Zahuranec DB, Brown DL, Lisabeth LD,Gonzales NR, PJ Longwell, Smith MA, Garcia NM, Morgenstern LB. Ethnic differences in do-not-resuscitate orders after intracerebral hemorrhage. Crit Care Med 2009; 37: 2807-2811.

17. Smith MA, Lisabeth LD, Bonikowski F, Morgenstern LB. The role of ethnicity, sex, and language on delay to hospital arrival for acute ischemic stroke. Stroke 2010;41:905-909.

18. Lisabeth LD, Sánchez BN, Escobar J, Hughes R, Meurer WJ, Zuniga B, Garcia N, Brown DL, Morgenstern LB. The food environment in an urban Mexican American community. Health and Place 2010; 16:598-605.

19. Skolarus LE, Sánchez BN, Morgenstern LB, Garcia NM, Smith MA, Brown DL, Lisabeth LD. Validity of proxies and correction for proxy use when evaluating social determinants of health in stroke patients. Stroke 2010;41:510-515.

20. Smith MA, Lisabeth LD, Bonikowski F, Morgenstern LB. The Role of Ethnicity, Sex and Language on Delay to Hospital Arrival for Acute Ischemic Stroke. Stroke 2010; 41:905-909.

21. Cantu-Brito C, Majersik JJ, Sanchez BN Ruano A, Quiñónez G, Arbola J, Morgenstern LB. Hospitalized stroke surveillance in the community of Durango Mexico—the Brain Attack Surveillance in Durango (BASID) Study. Stroke 2010; 41: 878-884.

22. Zahuranec DB, Morgenstern LB, Sánchez BN, Resnicow K, White DB, Hemphill JC 3rd.Do-not-resuscitate orders and predictive models after intracerebral hemorrhage.Neurology. 2010;75:626-633.

23. Simpson JR, Zahuranec DB, Lisabeth LD, Sánchez BN, Skolarus LE, Mendizabal JE, Smith MA, Garcia NM, Morgenstern LB. Mexican Americans with atrial fibrillation have more recurrent strokes than do non-Hispanic whites. Stroke 2010;41:2132-2136.

24. Kerber KA, Burke JF, Brown DL, Meurer WJ, Smith MA, Lisabeth LD, Morgenstern LB, Zahuranec DB. Does intracerebral hemorrhage mimic benign dizziness presentations? A population based study. Emerg Med J 2012; 29: 43-46.

25. Cantu-Brito C, Majersik JJ, Sánchez BN, Ruano A, Becerra-Mendoza D, Wing JJ, Morgenstern LB. Door-to-Door Capture of Incident and Prevalent Stroke Cases in Durango, Mexico: The Brain Attack Surveillance in Durango Study. Stroke 2011;42:601-606.

26. Skolarus LE, Lisabeth LD, Sánchez BN, Smith MA, Garcia NM, Risser, Morgenstern LB.The Prevalence of Spirituality, Optimism, Depression, and Fatalism in a Bi-ethnic Stroke Population. J Relig Health 2010 Dec 24. [Epub ahead of print]

27. Lisabeth LD, Morgenstern LB, Wing JJ, Sanchez BN, Zahuranec DB, Skolarus LE, Burke JF, Kleerekoper M, Smith MA, Brown DL. Poststroke Fractures in A Bi-ethnic Community. J Stroke Cerebrovasc Dis 2011 Feb 18. [Epub ahead of print]

28. Lisabeth LD, Morgenstern LB, Burke DT, Sun YV, Long JC. Ancestral heterogeneity in a biethnic stroke population. Ann Hum Genet. 2011;75:508-515.

29. Morgenstern, LB, Sánchez BN, Skolarus LE, Garcia N, Risser JMH, Wing JJ, Smith MA, Zahuranec DB, Lisabeth LD. Fatalism, optimism, spirituality, depressive symptoms and stroke outcome: A population-based analysis. Stroke 2011;42:3518-3523.

30. Skolarus LE, Lisabeth LD, Morgenstern LB, Burgin W, Brown DL. Sleep Apnea Risk Among Mexican American and Non-Hispanic White Stroke Survivors. Stroke 2012;43:1143-1145.

31. Sealy-Jefferson S, Wing JJ, Sánchez BN, Brown DL, Meurer WJ, Smith MA, Morgenstern LB, Lisabeth LD. Age- and Ethnic-Specific Sex Differences in Stroke Risk.Gend Med 2012; 9: 121-128.

1. Lisabeth LD, Brown DL, Hughes R, Majersik JJ, Morgenstern LB. (2009). Acute Stroke Symptoms Comparing Women and Men. Stroke, 2031-2036.

2. Brown DL, Feskanich D, Sanchez BN, Rexrode KM, Schernhammer ES, Lisabeth LD. (2009). Rotating Night Shift Work and Risk of Ischemic Stroke. American Journal of Epidemiology, 169, 1370-1377.

3. Reeves M, Bhatt A, Jajou P, Brown M, Lisabeth LD. (2009). Sex Differences in the Use of Intravenous rt-PA Thrombolysis Treatment for Acute Ischemic Stroke. A Meta-Analysis. Stroke, 40, 1743-1749.

4. Lisabeth LD, Diez-Roux, A.V., Escobar, J.D., Smith, M.A., Morgenstern, L.B. (2007). Neighborhood Environments and Risk of Ischemic Stroke: The Brain Attack Surveillance in Corpus Christi Project (BASIC). American Journal of Epidemiology, 165, 279-287.

1. Alasubramanian P, Sirivelu MP, Weiss KA, Wagner JG, Harkema JR, Morishita M, Mohankumar PS, Mohankumar SM. (2013) Differential effects of inhalation exposure to PM(2.5) on hypothalamic monoamines and corticotrophin releasing hormone in lean and obese rats. Neurotoxicology. 36:106-111. PubMed PMID: 22426024.

2. Blazek A, Rustky J, Osei K, Maiseyeu A, Sanjay Rajagopalan. (2013) Exercise-mediated changes in high-density lipoprotein: Impact on form and function. American Heart Journal. 166(3):392-400. PubMed PMID: 24016485.

3. Brook RD, Bard RL, Kaplan MJ, Yalavarthi S, Morishita M, Dvonch JT, Wang L, Yang HY, Spino C, Mukherjee B, Oral EA, Sun Q, Brook JR, Harkema J, Rajagopalan S. (2013) The effect of acute exposure to coarse particulate matter air pollution in a rural location on circulating endothelial progenitor cells: results from a randomized controlled study. Inhal Toxicol. 25(10):587-592. PubMed PMID: 23919441.

4. Brook RD, Xu X, Bard RL, Dvonch JT, Morishita M, Kaciroti N, Sun Q, Harkema J, Rajagopalan S. (2013) Reduced metabolic insulin sensitivity following sub-acute exposures to low levels of ambient fine particulate matter air pollution. Sci
Total Environ. 448:66-71. PubMed PMID: 22901427.

5. Brook RD, Bard RL, Morishita M, Dvonch JT, Wang L, Yang HY, Spino C, Mukherjee B, Kaplan MJ, Yalavarthi S, Oral EA, Ajluni N, Sun Q, Brook JR, Harkema J, Rajagopalan S. (2014) Hemodynamic, Autonomic, and Vascular Effects of Exposure to Coarse Particulate Matter Air Pollution from a Rural Location. Environ Health Perspect; 122; 624-30. PubMed PMID: 24618231.

6. Byrd JB, Morishita M, Bard RL, Das R, Wang L, Sun Z, Spino C, Harkema J, Dvonch JT, Rajagopalan S, Brook RD (2016). Acute increase in blood pressure during inhalation of coarse particulate matter air pollution from an urban location. Am Soc Hypertens. 10(2):133-139.e4. PubMed PMID: 26750378.

7. Kumagai K, Lewandowski R, Jackson-Humbles DN, Li N, Van Dyken SJ, Wagner JG, Harkema JR (2015). Ozone-induced Nasal Type 2 Immunity in Mice is Dependent on Innate Lymphoid Cells. Am J Respir Cell Mol Biol. [Epub ahead of print] PubMed PMID: 26559808.

8. Liu C, Bai Y, Xu X, Sun L, Wang A., Wang TY, Maurya SK, Periasamy M, Morishita M, Harkema J, Ying Z, Sun Q, Rajagopalan S. (2014) Exaggerated effects of particulate matter air pollution in genetic type II diabetes mellitus. Particle Fibre Toxicol. 11:27. PubMed PMID: 24886175.

9. Liu C, Xu X, Bai Y, Wang TY, Rao X, Wang A, Sun L, Ying Z, Gushchina L, Maiseyeu A, Morishita M, Sun Q, Harkema JR, Rajagopalan S. 2014. Air Pollution-Mediated Susceptibility to Inflammation and Insulin Resistance: Influence of CCR2 Pathways in Mice. Environ Health Perspect. 122:17-26. PubMed PMID: 24149114.

10. Liu C, Zheing Y, Harkema J, Sun Q, Rajagopalan S. (2013) Epidemiological and Experimental Links between Air Pollution and Type 2 Diabetes. Toxicol Pathol. 41(2):361-373. PubMed PMID: 23104765.

11. Maiseyeu A, Yang HY, Ramanathan G, Yin F, Bard RL, Morishita M, Dvonch JT, Wang L, Spino C, Mukherjee B, Badgeley MA, Barajas-Espinosa A, Sun Q, Harkema J, Rajagopalan S, Araujo JA, Brook RD. (2014) No effect of acute exposure to coarse particulate matter air pollution in a rural location on high-density lipoprotein function. Inhal Toxicol. 26(1):23-9. PubMed PMID: 24417404.

12. Morishita M, Bard RL, Kaciroti N, Fitzner CA, Dvonch T, Harkema JR, Rajagopalan S, Brook RD. (2014) Exploration of the composition and sources of urban fine particulate matter associated with same-day cardiovascular health effects in Dearborn, Michigan. J Expo Sci Environ Epidemiol [Epub ahead of print] PubMed PMID: 24866265.

13. Morishita M, Bard RL, Wang L, Das R, Dvonch JT, Spino C, Mukherjee B, Sun Q, Harkema JR, Rajagopalan S, Brook RD. (2014) The characteristics of coarse particulate matter air pollution associated with alterations in blood pressure and heart rate during controlled exposures. J Expo Sci Environ Epidemiol. PubMed PMID: 25227729.

14. Ong CB, Kumagai K, Brooks PT, Brandenberger C, Lewandowski RP, Jackson-Humbles DN, Nault R, Zacharewski TR, Wagner JG, Harkema JR.(2015). Ozone-Induced Type 2 Immunity in Nasal Airways: Development and Lymphoid Cell Dependence in Mice. Am J Respir Cell Mol Biol. [Epub ahead of print] PubMed PMID: 26203683.

15. Pancras JP, Landis MS, Norris GA, Vedantham R, Dvonch JT. (2013) Source apportionment of ambient fine particulate matter in Dearborn, Michigan, using hourly resolved PM chemical composition data. Sci Total Environ. 448:2-13. PubMed PMID:23302684.

16. Rao X, Zhong J, Maiseyeu A, Gopalakrishnan B, Villamena FA, Chen LC, Harkema JR, Sun Q, Rajagopalan S. (2014) CD36-Dependent 7-Ketocholesterol Accumulation in Macrophages Mediates Progression of Atherosclerosis in Response to Chronic Air Pollution Exposure. Circ Res. PubMed PMID: 25186795.

17. Sun L, Liu C, Xu X, Ying Z, Maiseyeu A, Wang A, Allen K, Lewandowski RP, Bramble LA, Morishita M, Wagner JG, Dvonch JT, Sun Z, Yan X, Brook RD, Rajagopalan S, Harkema JR, Sun Q, Fan Z. (2013) Ambient fine particulate matter and ozone exposures induce inflammation in epicardial and perirenal adipose tissues in rats fed a high fructose diet. Part Fibre Toxicol. 10(1):43. PubMed PMID: 23968387. PMCID:PMC3765456.

18. Wagner JG, Kamal AS, Morishita M, Dvonch JT, Harkema J, Rohr AC. (2014) PM2.5-induced cardiovascular dysregulation in rats is associated with elemental carbon and temperature-resolved carbon subfractions. Particle Fibre Toxicol. 11:25. PubMed PMID: 24885999.

19. Wagner JG, Allen K, Yang HY, Nan B, Morishita M, Mukherjee B, Dvonch JT, Spino C, Fink GD, Rajagopalan S, Sun Q, Brook RD, Harkema JR. (2014) Cardiovascular Depression in Rats Exposed to Inhaled Particulate Matter and Ozone: Effects of Diet-Induced Metabolic Syndrome. Environ Health Perspect. 122: 27-33. PubMed PMID: 24169565.

20. Ying Z, Xu X, Bai Y, Zhong J, Chen M, Liang Y, Zhao J, Liu D, Morishita M, Sun Q, Spino C, Brook RD, Harkema JR, Rajagopalan S. (2014) Long-Term Exposure to Concentrated Ambient PM2.5 Increases Mouse Blood Pressure through Abnormal Activation of the Sympathetic Nervous System: A Role for Hypothalamic Inflammation. Environ Health Perspect. 122: 79-86. PubMed PMID: 24240275.

21. Ying Z, Xu X, Chen M, Liu D, Zhong M, Chen LC, Sun Q, Rajagopalan S. (2013) A Synergistic Vascular Effect of Airborne Pariculate Matter and Nickel in a Mouse Model. Toxicol Sci. PubMed PMID: 23788629.

22. Ying Z, Allen K, Zhong J, Chen M, Williams KM, Wagner JG, Lewandowski R, Sun Q, Rajagopalan S, Harkema JR. (2016) Subacute inhalation exposure to ozone induces systemic inflammation but not insulin resistance in a diabetic mouse model. Inhal Toxicol. 4:155-63. PubMed PMID: 26986950.

23. Zhong J, Allen K, Rao X, Ying Z, Braunstein Z, Kankanala SR, Xia C, Wang X, Bramble LA, Wagner JG, Lewandowski R, Sun Q, Harkema JR, Rajagopalan S. (2016) Repeated Ozone Exposure Exacerbates Insulin Resistance And Activates Innate Immune Response In Genetically Susceptible Mice. Inhal Toxicol. 1-10. [Epub ahead of print] PubMed PMID: 27240593.

1. Shneider BL, Magee JC, Karpen SJ, Rand EB, Narkewicz MR, Bass LM, Schwarz K, Whitington PF, Bezerra JA, Kerkar N, Haber B, Rosenthal P, Turmelle YP, Molleston JP, Murray KF, Ng VL, Wang KS, Romero R, Squires RH, Arnon R, Sherker AH, Moore J, Ye W, Sokol RJ, Childhood Liver Disease Research Network Chi L.Total Serum Bilirubin within 3 Months of Hepatoportoenterostomy Predicts Short-Term Outcomes in Biliary Atresia. J Pediatr. 2016;170:211-7 e2. PubMed PMID: 26725209.

2. Karjoo S, Hand NJ, Loarca L, Russo PA, Friedman JR, and Wells RG. Extra-Hepatic Cholangiocyte Cilia are Abnormal in Biliary Atresia. Journal of Pediatric Gastroenterology and Nutrition. 2013; 57(1): 96-101.

3. Karjoo S, Wells RG. Isolation of Neonatal Extrahepatic Cholangiocytes. Journal of Visualized Experiments. 2014; 5(88): video.

4. Wang KS, Moss RL, Caty MG, Davidoff A, Fallat ME, Heiss KF, Holcomb G 3rd, Meyers RL, Watterberg KL, Aucott S, Benitz WE, Cummings JJ, Eichenwald EC, Goldsmith J, Poindexter BB, Puopolo K, Stewart DL, Wang KS, Kerkar N, Karpen SJ, Sokol RJ, Schwarz KB, Mogul DB, Harpavat S. Newborn Screening for Biliary Atresia. Pediatrics. 2015 Dec; 136(6):e1663-9. doi: 10.1542/peds.2015-3570.

5. Leung D, Ye W, Molleston J, Weymann A, Ling S, Paranjape S, Romero R, Schwarzenberg SJ, Palermo J, Alonso E, Murray K, Marshall B, Sherker A, Siegel M, Krishnamurthy R, Harned R, Karmazyn B, Magee J C, Narkewicz MR on behalf of the Cystic Fibrosis Liver Disease Network (CFLD NET). Baseline ultrasound and clinical correlates in children with Cystic Fibrosis. J Pediatrics. 2015 Oct; 167(4): 862-868.

6. Kamath BM, Chen Z, Romero R, Fredericks EM, Alonso EM, Arnon R, Heubi J, Hertel PM, Karpen SJ, Loomes KM, Murray KF, Rosenthal P, Schwarz KB, Subbarao G, Teckman JH, Turmelle YP, Wang KS, Sherker AH, Sokol RJ, Magee JC; Childhood Liver Disease Research Network (ChiLDReN). Quality of Life and its Determinants in a Multi-Center Cohort of Children with Alagille Syndrome. J Pediatrics. 2015 Aug;167(2):390-396.

7. Ogawa M, Ogawa S, Bear CE, Ahmadi S, Chin S, Li B, Grompe M, Keller G, Kamath BM, Ghanekar A.Directed differentiation of cholangiocytes from human pluripotent stem cells. Nat Biotechnol. 2015 Aug; 33(8):853.61.

8. Teckman JH, Rosenthal P, Abel R, Bass LM, Michail S, Murray KF, Rudnick DA, Thomas DW, Spino C, Arnon R, Hertel PM, Heubi J, Kamath BM, Karnsakul W, Loomes KM, Magee JC, Molleston JP, Romero R, Shneider BL, Sherker AH, Sokol RJ. Baseline Analysis of a Young Alpha-1-AT Deficiency Liver Disease Cohort Reveals Frequent Portal Hypertension. JPGN. 2015 (epub ahead of print).

9. Coughlin CR, Scharer GH, Friederich MW, Yu HC, Geiger EA, Creadon-Swindell G, Collins AE, Vanlander AV, Coster RV, Powell CA, Swanson MA, Minczuk M, Van Hove JL, Shaikh TH. Mutations in the mitochondrial cysteinyl-tRNA synthase gene, CARS2, lead to a severe epileptic encephalopathy and complex movement disorder. J Med Genet. 2015 (epub ahead of print).

10. Tsai EA, Grochowski CM, Falsey AM, Rajagopalan R, Wendel D, Devoto M, Krantz ID, Loomes KM, Spinner NB. Heterozygous Deletion of FOXA2 Segregates with Disease in a Family with Heterotaxy, Panhypopituitarism, and Biliary Atresia Human Mutation. 2015; 36(6): 631-7.

11. Lorent K, Gong W, Koo AK, Waisbourd-Zinman O, Karjoo S, Sealy I, Kettleborough RN, Stemple DL, Ueno Y, Windsor PA, Whittaker SJ, Porter JR, Wells RG, Pack M. Identification of a Plant Isoflavonoid that Causes Biliary Atresia. Sci Trans Med. 2015; 7(286):286ra67.

12. Wen Ye, Phil Rosenthal, John Magee and Peter Whitington. Factors Determining Delta-Bilirubin Levels in Biliary Atresia Infants. JPGN. 2015; 60(5):659-63.

13. Venkat VL, Shneider BL, Magee JC, Turmelle Y, Arnon R, Bezerra JA, Hertel PM, Karpen SJ, Kerkar N, Loomes KM, Molleston J, Murray KF, Ng VL, Raghunathan T, Rosenthal P, Schwartz K, Sherker AH, Sokol RJ, Teckman J, Wang K, Whitington PF, Heubi JE; Childhood Liver Disease Research and Education Network.Total serum bilirubin predicts fat-soluble vitamin deficiency better than serum bile acids in infants with biliary atresia. JPGN. 2014; 59(6):702-7.

14. Ng, Vicky Lee; Haber, Barbara H; Magee, John C; Miethke, Alexander; Murray, Karen F; Michail, Sonia; Karpen, Saul J; Kerkar, Nanda; Molleston, Jean P; Romero, Rene; Rosenthal, Philip; Schwarz, Kathleen B; Shneider, Benjamin L; Turmelle, Yumirle P; Alonso, Estella M; Sherker, Averell H; Sokol, Ronald J; Childhood Liver Disease Research and Education Network (CHiLDREN). Medical status of 219 children with biliary atresia surviving long-term with their native livers: results from a North American multicenter consortium. J Pediatr. 2014; 165(3):539-546.

15. Heubi JE, Setchell KD, Jha P, Buckley D, Zhang W, Rosenthal P, Potter C, Horslen S, Suskind D. Treatment of bile acid amidation defects with glycocholic acid. Hepatology. 2015; 61(1):268-74.

16. Bessho, Kazuhiko; Mourya, Reena; Shivakumar, Pranavkumar; Walters, Stephanie; Magee, John C; Rao, Marepalli; Jegga, Anil G; Bezerra, Jorge A. Gene expression signature for biliary atresia and a role for interleukin-8 in pathogenesis of experimental disease. Hepatology. 2014; 60(1):211-23.

17. Bezerra, Jorge A; Spino, Cathie; Magee, John C; Shneider, Benjamin L; Rosenthal, Philip; Wang, Kasper S; Erlichman, Jessi; Haber, Barbara; Hertel, Paula M; Karpen, Saul J; Kerkar, Nanda; Loomes, Kathleen M; Molleston, Jean P; Murray, Karen F; Romero, Rene; Schwarz, Kathleen B; Shepherd, Ross; Suchy, Frederick J; Turmelle, Yumirle P; Whitington, Peter F; Moore, Jeffrey; Sherker, Averell H; Robuck, Patricia R; Sokol, Ronald J; Childhood Liver Disease Research and Education Network (ChiLDREN). Use of corticosteroids after hepatoportoenterostomy for bile drainage in infants with biliary atresia: the START randomized clinical trial. JAMA. 2014; 311(17):1750-9.

18. Sambrotta, Melissa; Strautnieks, Sandra; Papouli, Efterpi; Rushton, Peter; Clark, Barnaby E; Parry, David A; Logan, Clare V; Newbury, Lucy J; Kamath, Binita M; Ling, Simon; Grammatikopoulos, Tassos; Wagner, Bart E; Magee, John C; Sokol, Ronald J; Mieli-Vergani, Giorgina; University of Washington Center for Mendelian Genomics; Smith, Joshua D; Johnson, Colin A; McClean, Patricia; Simpson, Michael A; Knisely, A S; Bull, Laura N; Thompson, Richard J. Mutations in TJP2 cause progressive cholestatic liver disease Nat Genet. 2014; 46(4):326-8.

19. Tsai EA, Grochowski CM, Loomes KM, Bessho K, Hakonarson H, Bezerra JA, Russo PA, Haber BA, Spinner NB, Devoto M. Replication of a GWAS signal in a Caucasian population implicates ADD3 in susceptibility to biliary atresia Hum Genet. 2014; 133(2):235-43.

20. Cui, S., Leyva-Vega, M., Tsai, E. A., EauClaire, S. F., Glessner, J. T., Hakonarson, H., Devoto, M., Haber, B. A., Spinner, N. B., Matthews, R. P. Evidence from human and zebrafish that GPC1 is a biliary atresia susceptibility gene. Gastroenterology. 2013; 144(5):1107-15.

21. K. D. Setchell, J. E. Heubi, S. Shah, J. E. Lavine, D. Suskind, M. Al-Edreesi, C. Potter, D. W. Russell, N. C. O'Connell, B. Wolfe, P. Jha, W. Zhang, K. E. Bove, A. S. Knisely, A. F. Hofmann, P. Rosenthal and L. N. Bull.Genetic defects in bile acid conjugation cause fat-soluble vitamin deficiency. Gastroenterology. 2013; 144(5):945-55.

22. Mealer M, Kittelson J, Thompson BT, Wheeler AP, Magee JC, Sokol RJ, Moss M, and. Kahn MG. Remote source document verification in two national clinical trials networks: A pilot study. PLoS One. 2013; 8(12).

23. Mack CL, Anderson KM, Aubrey MT, Rosenthal P, Sokol RJ and Freed BM. Lack of HLA predominance and HLA shared epitopes in biliary Atresia. SpringerPlus. 2013; 2(1):1-13.

24. Molleston JP, Sokol RJ, Karnsakul W, Miethke A, Horslen S, Magee JC, Romero R, Squires RH and Van Hove JL for Childhood Liver Disease Research and Education Network. Evaluation of the child with suspected mitochondrial liver disease J Pediatr Gastroenterol Nutr. 2013; 57(3):269-276.

25. Schwarz KB, Haber BH, Rosenthal P, Mack CL, Moore J, Bove, K, Bezerra JA, Karpen SJ, Kerkar N, Shneider BL, Turmelle YP, Whitington PF, Molleston JP, Murray KF, Ng VL, Romero R, Wang KS, Sokol RJ and Magee JC for Childhood Liver Disease Research and Education Network. Extra-hepatic anomalies in infants with biliary atresia: results of a large prospective North American multi-center study. Hepatology. 2013; 58(5):1724-31.

26. Sundaram SS, Alonso EM, Haber B, Magee JC, Fredericks E, Kamath B, Kerkar N, Rosenthal P, Shepherd R, Limbers C, Varni JW, Robuck P and Sokol RJ for Childhood Liver Disease Research and Education Network.Health related Quality of Life in patients with biliary atresia surviving with their native liver. J Pediatr. 2013; 163(4):1052-7.

27. Brindley SM, Lanham AM, Karrer FM, Tucker RM, Fontenot AP and Mack CL. Cytomegalovirus-specific T-cell reactivity in biliary atresia at the time of diagnosis is associated with deficits in regulatory T cells.Hepatology. 2012; 55(4):1130-1138.

28. Chu AS, Russo PA and Wells RG. Cholangiocyte cilia are abnormal in syndromic and non-syndromic biliary atresia. Mod Pathol. 2012; 25(5):751-757.

29. Kamath BM, Bauer RC, Loomes KM, Chao G, Gerfen J, Hutchinson A, Hardikar W, Hirschfield G, Jara P, Krantz ID, Lapunzina P, Leonard L, Ling S, Ng VL, Hoang PL, Piccoli DA and Spinner NB. NOTCH2 mutations in Alagille syndrome. J Med Genet. 2012; 49(2):138-144.

30. Mack CL, Feldman AG and Sokol RJ. Clues to the etiology of bile duct injury in biliary atresia. Semin Liver Dis. 2012; 32(4):307-316.

31. Kamath BM, Piccoli DA, Magee JC, and Sokol RJ for Childhood Liver Disease Research and Education Network. Pancreatic insufficiency is not a prevalent problem in Alagille syndrome. J Pediatr Gastroenterol Nutr. 2012; 55(5):612-614.

32. Penton AL, Leonard LD and Spinner NB. Notch signaling in human development and disease. Semin Cell Dev Biol. 2012; 23(4):450-457.

33. Sheridan RM, Gupta A, Miethke A, Knisely AS and Bove KE. (Letter to the editor) Multiple dysplastic liver nodules in PFIC2 underscore risk for neoplasia associated with functional BSEP deficiency. Am J Surg Pathol. 2012; 36(5):785-786.

34. Shneider BL, Abel RB, Haber B, Karpen SJ, Magee JC, Romero R, Schwarz K, Bass LM, Kerkar N, Miethke AG, Rosenthal P, Turmelle Y, Robuck PR and Sokol RJ for Childhood Liver Disease Research and Education Network. Portal hypertension in children and young adults with biliary atresia. J Pediatr Gastroenterol Nutr. 2012; 55(5):567-573.

35. Shneider BL, Magee JC, Bezerra JA, Haber B, Karpen SJ, Raghunathan T, Rosenthal P, Schwarz K, Suchy FJ, Kerkar N, Turmelle Y, Whitington PF, Robuck PR and Sokol RJ for Childhood Liver Disease Research and Education Network (ChiLDREN). Efficacy of fat soluble vitamin supplementation in infants with biliary atresia: a prospective multi-center analysis. Pediatrics. 2012; 130(3):e607-614.

36. Zahm AM, Hand NJ, Boateng LA and Friedman JR. Circulating microRNA is a biomarker of biliary atresia.J Pediatr Gastroenterol Nutr. 2012; 55(4):366-369.

37. Bessho K and Bezerra JA. Biliary atresia: will blocking inflammation tame the disease? Annu Rev Med. 2011; 62(X):171-185.

38. Chu AS, Diaz R, Hui JJ, Yanger K, Zong Y, Alpini G, Stanger BZ and Wells RG. Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis. Hepatology. 2011; 53(5):1685-1695.

39. Evason K, Bove KE, Finegold MJ, Knisely AS, Rhee S, Rosenthal P, Miethke AG, Karpen SJ, Ferrell LD and Kim GE. Morphologic findings in Progressive Familial Intrahepatic Cholestasis 2 (PFIC2): Correlation with genetic and immunohistochemical studies. Am J Surg Path. 2011; 35(5):687-696.

40. He M, Pei Z, Mohsen AW, Watkins P, Murdoch G, Van Veldhoven PP, Ensenauer R and Vockley J.Identification and characterization of new long chain acyl-CoA dehydrogenases. Mol Genet Metab. 2011; 102(4):418-429.

41. Li J, Bessho K, Shivakumar P, Mourya R, Mohanty SK, Dos Santos JL, Miura IK, Porta G and Bezerra JA. Th2 signals induce epithelial injury in mice and are compatible with the biliary atresia phenotype. J Clin Invest. 2011; 121(11):4244-4256.

42. Russo P, Magee JC, Boitnott J, Bove KE, Raghunathan T, Finegold M, Haas J, Jaffe R, Kim GE, Magid M, Melin-Aldana H, White F, Whitington PF, Sokol RJ for the Biliary Atresia Research Consortium. Design and validation of the Biliary Atresia Research Consortium histologic assessment system for cholestasis in infancy. Clin Gastroenterology and Hepatol. 2011; 9(4):357-362.

43. Saxena V, Shivakumar P, Sabla G, Mourya R, Chougnet C and Bezerra JA. Dendritic cells regulate natural killer cell activation and epithelial injury in experimental biliary atresia. Nature Rev Gastroenterol Hepatol 2011;8:660. Sci Transl Med. 2011; 3(102):102ra194.

44. Shin S, Walton G, Aoki R, Brondell K, Schug J, Fox A, Smirnova O, Dorrell C, Erker L, Chu AS, Wells RG, Grompe M, Greenbaum LE and Kaestner KH. Foxl1-Cre-marked adult hepatic progenitors have clonogenic and bilineage differentiation potential. Genes Dev. 2011; 25(11):1185-1192.

45. Superina R, Magee JC, Brandt ML, Healey PJ, Tiao G, Ryckman F, Karrer FM, Iyer K, Fecteau A, West K, Burns RC, Flake A, Lee H, Lowell JA, Dillon P, Colombani P, Ricketts R, Li Y, Moore J and Wang KS. for Childhood Liver Disease Research and Education Network (ChiLDREN). The anatomic pattern of biliary atresia identified at time of Kasai Hepatoportoenterostomy and early postoperative clearance of jaundice are significant predictors of transplant-free survival. Ann Surg. 2011; 254(4):577-585.

46. Leyva-Vega M, Gerfen J, Thiel BD, Jurkiewicz D, Rand EB, Pawlowska J, Kaminska D, Russo P, Gai X, Krantz ID, Kamath BM, Hakonarson H, Haber BA and Spinner NB. Genomic alterations in biliary atresia suggest region of potential disease susceptibility in 2q37.3. Am J Med Genet A. 2010; 152A(4):886-895.

47. Matte U, Mourya R, Miethke A, Liu C, Kauffmann G, Moyer K, Zhang K and Bezerra JA. Analysis of gene mutations in children with cholestasis of undefined etiology. J Pediatr Gastroenterol Nutr. 2010; 51(4):488-493.

48. Moyer K, Kaimal V, Pacheco C, Mourya R, Xu H, Shivakumar P, Chakraborty R, Rao M, Magee JC, Bove K, Aronow BJ, Jegga AG and Bezerra JA. Staging of biliary atresia at diagnosis by molecular profiling of the liver. Genome Med. 2010; 2(5):33.

49. Pawlikowska L, Strautnieks S, Jankowska I, Czubkowski P, Emerick K, Antoniou A, Wanty C, Fischler B, Jacquemin E, Wali S, Blanchard S, Nielsen IM, Bourke B, McQuaid S, Lacaille F, Byrne JA, van Eerde AM, Kolho KL, Klomp L, Houwen R, Bacchetti P, Lobritto S, Hupertz V, McClean P, Mieli-Vergani G, Shneider B, Nemeth A, Sokal E, Freimer NB, Knisely AS, Rosenthal P, Whitington PF, Pawlowska J, Thompson RJ and Bull LN. Differences in presentation and progression between severe FIC1 and BSEP deficiencies. J Hepatol. 2010; 53(1):170-178.

50. Sokol RJ. Reloading against rare liver diseases. J Pediatr Gastroenterol Nutr. 2010; 50(1):9-10.

51. Van Hove JLK, Saenz MS, Thomas JA, Gallagher RC, Lovell MA, Fenton LZ, Shanske S, Myers SM, Wanders RJ, Ruiter J, Turkenburg M and Waterham HR. Succinyl-CoA ligase deficiency: a mitochondrial hepatoencephalomyopathy. Pediatr Res. 2010; 68(2):159-164.

52. Wang H, Malone JP, Gilmore PE, Davis AE, Magee JC, Townsend RR and Heuckeroth RO. Serum markers may distinguish biliary atresia from other forms of neonatal cholestasis. J Pediatr Gastroenterol Nutr. 2010; 50(4):411-416.

53. Griggs RC, Batshaw M, Dunkle M, Gopal-Srivastava R, Kaye E, Krischer J, Nguyen T, Paulus K and Merkel PA.Clinical research for rare disease: opportunities, challenges, and solutions. Mol Genet Metab. 2009; 96(1):20-26.

54. Sokol RJ. Biliary atresia screening: why, when, and how? Pediatrics. 2009; 123(5):e951-952.

55. Swigonova Z, Mohsen AW and Vockley J. Acyl-CoA dehydrogenases: Dynamic history of protein family evolution J Mol Evol. 2009; 69(2):176-193.

56. Strautnieks SS, Byrne JA, Pawlikowska L, Cebecauerova D, Rayner A, Dutton L, Meier Y, Antoniou A, Stieger B, Arnell H, Ozcay F, Al-Hussaini HF, Bassas AF, Verkade HJ, Fischler B, Nemeth A, Kotalova R, Shneider BL, Cielecka-Kuszyk J, McClean P, Whitington PF, Sokal E, Jirsa M, Wali SH, Jankowska I, Pawlowska J, Mieli-Vergani G, Knisely AS, Bull LN and Thompson RJ. Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families. Gastroenterology. 2008; 134(4):1203-1214.

57. Sundaram SS, Bove KE, Lovell MA and Sokol RJ. Mechanisms of disease: inborn errors of bile acid synthesis. Nat Clin Pract Gastroenterol Hepatol. 2008; 5(8):456-468.

58. DeRusso PA, Ye W, Shepherd R, Haber BA, Shneider BL, Whitington PF, Schwarz KB, Bezerra JA, Rosenthal P, Karpen S, Squires RH, Magee JC, Robuck PR and Sokol RJ. for Biliary Atresia Research Consortium. Growth failure and outcomes in infants with biliary atresia: a report from the Biliary Atresia Research Consortium. J Hepatol. 2007; 46(5):1632-1638.

59. He M, Rutledge SL, Kelly DR, Palmer CA, Murdoch G, Majumder N, Nicholls RD, Pei Z, Watkins PA and Vockley J. A new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9 deficiency. Am J Hum Genet. 2007; 81(1):87-103.

60. Heubi JE, Setchell KD and Bove KE. Inborn errors of bile acid metabolism. Semin Liver Dis. 2007; 27(3):282-294.

61. Lee WS and Sokol RJ. Liver disease in mitochondrial disorders. Semin Liver Dis. 2007; 27(3):259-273.

62. Liu C, Aronow BJ, Jegga AG, Wang N, Miethke A, Mourya R and Bezerra JA. Novel resequencing chip customized to diagnose mutations in patients with inherited syndromes of intrahepatic cholestasis.Gastroenterology. 2007; 132(1):119-126.

63. Mack CL, Falta MT, Sullivan AK, Karrer F, Sokol RJ, Freed BM and Fontenot AP. Oligoclonal expansions of CD4+ and CD8+ T-cells in the target organ of patients with biliary atresia. Gastroenterology. 2007; 133(1):278-287.

64. Shneider BL, Bezerra JA, Sokol RJ and Whitington PF. Reply to: 'Multicenter Biliary Atresia Outcome Studies: the importance of surgical aspects by Petersen, et. al. J Pediatr. 2007; 150(6):e89-e90.

65. Sokol RJ, Shepherd RW, Superina R, Bezerra JA, Robuck P and Hoofnagle JH. Screening and outcomes in biliary atresia: summary of a National Institutes of Health workshop. J Hepatol. 2007; 46(2):566-581.

1. AG Visco, JT Wei, LA McClure, VL Handa & IE Nygaard, for the Pelvic Floor Disorders Network. Effects of examination technique modifications on Pelvic Organ Prolapse-Quantification (POP-Q) results. (2003). Int Urogynecol J Pelvic Floor Dysfunct, 14(2):136-140. [1J03] [PMID: 12851759]
2. L Brubaker, G Cundiff, P Fine, I Nygaard, H Richter, A Visco, H Zyczynski, MB Brown & A Weber, for the Pelvic Floor Disorders Network. A randomized trial of Colpopexy And urinary Reduction Efforts (CARE): design and methods. (2003). Control Clin Trials, 24(5):629-642. [1A16] [PMID: 14500059]
3. IE Nygaard, R McCreery, L Brubaker, A Connolly, G Cundiff, AM Weber & H Zyczynski, Abdominal sacrocolpopexy: a comprehensive review. (2004). Obstet Gynecol, 104(4):805-823. [1R01] [PMID: 15458906]
4. S Kwon, AG Visco, MP Fitzgerald, W Ye & WE Whitehead, for the Pelvic Floor Disorders Network. Validity and reliability of the Modified Manchester Health Questionnaire in assessing patients with fecal incontinence. (2005). Dis Colon Rectum, 48(2):323-331; discussion 331-324. [2J01] [PMID: 15616750]
5. PA Wren, NK Janz, L Brubaker, MP Fitzgerald, AM Weber, FB LaPorte & JT Wei, for the Pelvic Floor Disorders Network. Reliability of health-related quality-of-life measures 1 year after surgical procedures for pelvic floor disorders. (2005). Am J Obstet Gynecol, 192(3):780-788. [1J01] [PMID: 15746672]
6. MP FitzGerald, HE Richter, S Siddique, P Thompson & H Zyczynski, for the Pelvic Floor Disorders Network. Colpocleisis: a review. (2006). Int Urogynecol J Pelvic Floor Dysfunct, 17(3):261-271. [7R01] [PMID: 15983731]
7. AF Hundley, MB Brown, L Brubaker, GW Cundiff, K Kreder, P Lotze, HE Richter, H Zyczynski, AM Weber & AG Visco, A multicentered comparison of measurements obtained with microtip and external water pressure transducers. (2006). Int Urogynecol J Pelvic Floor Dysfunct, 17(4):400-406. [1J05] [PMID: 16284710]
8. L Brubaker, GW Cundiff, P Fine, I Nygaard, HE Richter, AG Visco, H Zyczynski, MB Brown & AM Weber, for the Pelvic Floor Disorders Network. Abdominal sacrocolpopexy with Burch colposuspension to reduce urinary stress incontinence. (2006). N Engl J Med, 354(15):1557-1566. [1P01a] [PMID: 16611949]
9. I Nygaard, V Handa, L Brubaker, D Borello-France, J Wei, E Wells & AM Weber, for the Pelvic Floor Disorders Network. Physical activity in women planning sacrocolpopexy. (2007). Int Urogynecol J Pelvic Floor Dysfunct, 18(1):33-37. [1A02a] [PMID: 16688397]
10. D Borello-France, KL Burgio, HE Richter, H Zyczynski, MP Fitzgerald, W Whitehead, P Fine, I Nygaard, VL Handa, AG Visco, AM Weber & MB Brown, for the Pelvic Floor Disorders Network. Fecal and urinary incontinence in primiparous women. (2006). Obstet Gynecol, 108(4):863-872. [2P01a] [PMID: 17012447]
11. CS Bradley, MB Brown, GW Cundiff, PS Goode, KS Kenton, IE Nygaard, WE Whitehead, PA Wren & AM Weber, for the Pelvic Floor Disorders Network. Bowel symptoms in women planning surgery for pelvic organ prolapse. (2006). Am J Obstet Gynecol, 195(6):1814-1819. [1A19a] [PMID: 16996465]
12. HE Richter, JR Fielding, CS Bradley, VL Handa, P Fine, MP FitzGerald, A Visco, A Wald, C Hakim, JT Wei & AM Weber, for the Pelvic Floor Disorders Network. Endoanal ultrasound findings and fecal incontinence symptoms in women with and without recognized anal sphincter tears. (2006). Obstet Gynecol, 108(6):1394-1401. [2S02a] [PMID: 17138772]
13. MP Fitzgerald, AM Weber, N Howden, GW Cundiff & MB Brown, for the Pelvic Floor Disorders Network. Risk factors for anal sphincter tear during vaginal delivery. (2007). Obstet Gynecol, 109(1):29-34. [2A09] [PMID: 17197584]
14. L Brubaker, K Kreder, H Richter, J Lavelle, J Wei, S Mahajan & W AM, for the Pelvic Floor Disorders Network. Refractory Urge urinary incontinence and Botulinum A Injection: The methods of the RUBI trial. (2006). Journal of Applied Research, 6(4):260-271. [12M01] [PMID: Not indexed]
15. HE Richter, KL Burgio, PS Goode, D Borello-France, CS Bradley, L Brubaker, VL Handa, PM Fine, AG Visco, HM Zyczynski, JT Wei & AM Weber, for the Pelvic Floor Disorders Network. Non-surgical management of stress urinary incontinence: Ambulatory Treatments for Leakage Associated with Stress (ATLAS) trial. (2007). Clin Trials, 4(1):92-101. [13M01] [PMID: 17327249]
16. DF Borello-France, VL Handa, MB Brown, P Goode, K Kreder, LL Scheufele & AM Weber, for the Pelvic Floor Disorders Network. Pelvic-floor muscle function in women with pelvic organ prolapse. (2007). Phys Ther, 87(4):399-407. [1A13a] [PMID: 17341510]
17. L Brubaker, CS Bradley, VL Handa, HE Richter, A Visco, MB Brown & AM Weber, for the Pelvic Floor Disorders Network. Anal sphincter laceration at vaginal delivery: is this event coded accurately? (2007). Obstet Gynecol, 109(5):1141-1145. [2A10] [PMID: 17470596]
18. HE Richter, PS Goode, K Kenton, MB Brown, KL Burgio, K Kreder, P Moalli, EJ Wright & AM Weber, for the Pelvic Floor Disorders Network. The effect of age on short-term outcomes after abdominal surgery for pelvic organ prolapse. (2007). J Am Geriatr Soc, 55(6):857-863. [1A08] [PMID: 17537085]
19. P Wren, N Janz, L Brubaker, D Borello-France, C Bradley, K Burgio, G Cundiff, A Weber & W J, Development of the Measure of Adaptations for Pelvic Symptoms (MAPS): the importance of incorporating the female patient's voice. (2007). Applied Research in QOL, 1(3-4):239-251. [1J06] [PMID: Not indexed]
20. MP Fitzgerald, NK Janz, PA Wren, JT Wei, AM Weber, C Ghetti & GW Cundiff, for the Pelvic Floor Disorders Network. Prolapse severity, symptoms and impact on quality of life among women planning sacrocolpopexy. (2007). Int J Gynaecol Obstet, 98(1):24-28. [1A05a] [NIHMS 26880] [PMID: 17477927]
21. WE Whitehead, CS Bradley, MB Brown, L Brubaker, RE Gutman, RE Varner, AG Visco, AM Weber & H Zyczynski, for the Pelvic Floor Disorders Network. Gastrointestinal complications following abdominal sacrocolpopexy for advanced pelvic organ prolapse. (2007). Am J Obstet Gynecol, 197(1):78 e71-77. [1A20] [PMC2921839] [PMID: 17618767]
22. P Fine, K Burgio, D Borello-France, H Richter, W Whitehead, A Weber & M Brown, for the Pelvic Floor Disorders Network. Teaching and practicing of pelvic floor muscle exercises in primiparous women during pregnancy and the postpartum period. (2007). Am J Obstet Gynecol, 197(1):107 e101-105. [2A07] [PMID: 17618779]
23. KL Burgio, D Borello-France, HE Richter, MP Fitzgerald, W Whitehead, VL Handa, I Nygaard, P Fine, H Zyczynski, AG Visco, MB Brown & AM Weber, for the Pelvic Floor Disorders Network. Risk factors for fecal and urinary incontinence after childbirth: the childbirth and pelvic symptoms study. (2007). Am J Gastroenterol, 102(9):1998-2004. [2P01b] [PMID: 17573795]
24. HE Richter, I Nygaard, KL Burgio, VL Handa, MP Fitzgerald, P Wren, H Zyczynski, P Fine, MB Brown & AM Weber, for the Pelvic Floor Disorders Network. Lower urinary tract symptoms, quality of life and pelvic organ prolapse: irritative bladder and obstructive voiding symptoms in women planning to undergo abdominal sacrocolpopexy for advanced pelvic organ prolapse. (2007). J Urol, 178(3 Pt 1):965-969; discussion 969. [1J10C] [PMID: 17632167]
25. AE Young, PM Fine, R McCrery, PA Wren, HE Richter, L Brubaker, MB Brown & AM Weber, for the Pelvic Floor Disorders Network. Spanish language translation of pelvic floor disorders instruments. (2007). Int Urogynecol J Pelvic Floor Dysfunct, 18(10):1171-1178. [2J03] [PMID: 17576498]
26. I Nygaard, K Kreder, E Mueller, L Brubaker, P Goode, A Visco, AM Weber, G Cundiff & J Wei, for the Pelvic Floor Disorders Network. Does urethral competence affect urodynamic voiding parameters in women with prolapse? (2007). Neurourol Urodyn, 26(7):1030-1035. [1J10a] [PMID: 17638306]
27. CS Bradley, HE Richter, RE Gutman, MB Brown, WE Whitehead, PM Fine, C Hakim, F Harford & AM Weber, for the Pelvic Floor Disorders Network. Risk factors for sonographic internal anal sphincter gaps 6-12 months after delivery complicated by anal sphincter tear. (2007). Am J Obstet Gynecol, 197(3):310 e311-315. [2S02b] [PMID: 17826433]
28. VL Handa, HM Zyczynski, L Brubaker, I Nygaard, NK Janz, HE Richter, PA Wren, MB Brown & AM Weber, for the Pelvic Floor Disorders Network. Sexual function before and after sacrocolpopexy for pelvic organ prolapse. (2007). Am J Obstet Gynecol, 197(6):629 e621-626. [1A11a/b] [PMC2367128] [PMID: 18060957]
29. KL Burgio, IE Nygaard, HE Richter, L Brubaker, RE Gutman, W Leng, J Wei & AM Weber, for the Pelvic Floor Disorders Network. Bladder symptoms 1 year after abdominal sacrocolpopexy with and without Burch colposuspension in women without preoperative stress incontinence symptoms. (2007). Am J Obstet Gynecol, 197(6):647 e641-646. [1P01c] [PMID: 18060965]
30. CS Bradley, IE Nygaard, MB Brown, RE Gutman, KS Kenton, WE Whitehead, PS Goode, PA Wren, C Ghetti & AM Weber, for the Pelvic Floor Disorders Network. Bowel symptoms in women 1 year after sacrocolpopexy. (2007). Am J Obstet Gynecol, 197(6):642 e641-648. [1A19b] [PMID: 18060963]
31. VL Handa, HM Zyczynski, KL Burgio, MP Fitzgerald, D Borello-France, NK Janz, PM Fine, W Whitehead, MB Brown & AM Weber, for the Pelvic Floor Disorders Network. The impact of fecal and urinary incontinence on quality of life 6 months after childbirth. (2007). Am J Obstet Gynecol, 197(6):636 e631-636. [2P01c] [PMID: 18060960]
32. AG Visco, L Brubaker, I Nygaard, HE Richter, G Cundiff, P Fine, H Zyczynski, MB Brown, AM Weber & PFDN, The role of preoperative urodynamic testing in stress-continent women undergoing sacrocolpopexy: the Colpopexy And urinary Reduction Efforts (CARE) randomized surgical trial. (2008). Int Urogynecol J Pelvic Floor Dysfunct, 19(5):607-614. [1P01b] [PMC2597273] [PMID: 18185903]
33. L Brubaker, VL Handa, CS Bradley, A Connolly, P Moalli, MB Brown & A Weber, for the Pelvic Floor Disorders Network. Sexual function 6 months after first delivery. (2008). Obstet Gynecol, 111(5):1040-1044. [2A05] [PMC2593132] [PMID: 18448733]
34. VL Handa, ME Lockhart, JR Fielding, CS Bradley, L Brubaker, GW Cundiff, W Ye & HE Richter, for the Pelvic Floor Disorders Network. Racial differences in pelvic anatomy by magnetic resonance imaging. (2008). Obstet Gynecol, 111(4):914-920. [2A13] [PMC2593128] [PMID: 18378751]
35. I Nygaard, VL Handa, L Brubaker, D Borello-France, J Wei, E Wells & P Goode, for the Pelvic Floor Disorders Network. Changes in physical activity after abdominal sacrocolpopexy for advanced pelvic organ prolapse. (2008). Am J Obstet Gynecol, 198(5):570 e571-575. [1A02b] [PMC2391281] [PMID: 18455536]
36. L Brubaker, HE Richter, A Visco, S Mahajan, I Nygaard, TM Braun, MD Barber, S Menefee, J Schaffer, AM Weber & J Wei, for the Pelvic Floor Disorders Network. Refractory idiopathic Urge urinary incontinence and Botulinum A Injection. (2008). J Urol, 180(1):217-222. [12P01] [PMC2597793] [PMID: 18499184]
37. PA Wren, NK Janz, MP FitzGerald, MD Barber, KL Burgio, GW Cundiff, IE Nygaard, HM Zyczynski & X Gao, for the Pelvic Floor Disorders Network. Optimism in women undergoing abdominal sacrocolpopexy for pelvic organ prolapse. (2008). J Am Coll Surg, 207(2):240-245. [1A14] [PMID: 18656053]
38. E Mueller, J Wei, I Nygaard, L Brubaker, E Varner, A Visco, GW Cundiff, AM Weber, C Ghetti & K Kreder, The correlation of voiding variables between non-instrumented uroflometery and pressure-flow studies in women with pelvic organ prolapse. (2008). Neurourol Urodyn, 27(6):515-521. [1J10B] [PMID: 18551567]
39. PS Goode, MP Fitzgerald, HE Richter, WE Whitehead, I Nygaard, PA Wren, HM Zyczynski, G Cundiff, S Menefee, JM Senka, X Gao & AM Weber, for the Pelvic Floor Disorders Network. Enhancing participation of older women in surgical trials. (2008). J Am Coll Surg, 207(3):303-311. [1A21] [PMID: 18722933]
40. L Brubaker, I Nygaard, HE Richter, A Visco, AM Weber, GW Cundiff, P Fine, C Ghetti & MB Brown, for the Pelvic Floor Disorders Network. Two-year outcomes after sacrocolpopexy with and without Burch to prevent stress urinary incontinence. (2008). Obstet Gynecol, 112(1):49-55. [1P01d] [PMC2614233] [PMID: 18591307]
41. ME Lockhart, JR Fielding, HE Richter, L Brubaker, CG Salomon, W Ye, CM Hakim, CY Wai, AH Stolpen & AM Weber, Reproducibility of dynamic MR imaging pelvic measurements: a multi-institutional study. (2008). Radiology, 249(2):534-540. [2A20] [PMC2657864] [PMID: 18796659]
42. I Nygaard, MD Barber, KL Burgio, K Kenton, S Meikle, J Schaffer, C Spino, WE Whitehead, J Wu & DJ Brody, for the Pelvic Floor Disorders Network. Prevalence of symptomatic pelvic floor disorders in US women. (2008). JAMA, 300(11):1311-1316. [NHANES-EPI] [PMCID2918416] [PMID: 18799443]
43. MP Fitzgerald, HE Richter, CS Bradley, W Ye, AC Visco, GW Cundiff, HM Zyczynski, P Fine & AM Weber, for the Pelvic Floor Disorders Network. Pelvic support, pelvic symptoms, and patient satisfaction after colpocleisis. (2008). Int Urogynecol J Pelvic Floor Dysfunct, 19(12):1603-1609. [7P01] [PMCID Needed] [PMID: 18690402]
44. GW Cundiff, E Varner, AG Visco, HM Zyczynski, CW Nager, PA Norton, J Schaffer, MB Brown & L Brubaker, for the Pelvic Floor Disorders Network. Risk factors for mesh/suture erosion following sacral colpopexy. (2008). Am J Obstet Gynecol, 199(6):688 e681-685. [1A22] [PMC2859033] [PMID: 18976976]
45. CS Bradley, KS Kenton, HE Richter, X Gao, HM Zyczynski, AM Weber & IE Nygaard, for the Pelvic Floor Disorders Network. Obesity and outcomes after sacrocolpopexy. (2008). Am J Obstet Gynecol, 199(6):690 e691-698. [1A17] [PMC2918409] [PMID: 18845288]
46. VL Handa, ME Lockhart, KS Kenton, CS Bradley, JR Fielding, GW Cundiff, CG Salomon, C Hakim, W Ye & HE Richter, Magnetic resonance assessment of pelvic anatomy and pelvic floor disorders after childbirth. (2009). Int Urogynecol J Pelvic Floor Dysfunct, 20(2):133-139. [2S02c/d] [PMCID2916750] [PMID: 18846311]
47. MD Barber, L Brubaker, S Menefee, P Norton, D Borello-France, E Varner, J Schaffer, A Weidner, X Xu, C Spino & A Weber, for the Pelvic Floor Disorders Network. Operations and Pelvic muscle Training In the Management of Apical support Loss (OPTIMAL) trial: design and methods. (2009). Contemp Clin Trials, 30(2):178-189. [16M01] [PMC2646798] [PMID: 19130903]
48. J Wei, I Nygaard, H Richter, M Brown, M Barber, X Xiao, K Kenton, C Nager, J Schaffer, A Visco & A Weber, for the Pelvic Floor Disorders Network. Outcomes following vaginal Prolapse repair and mid Urethral Sling (OPUS) trial--design and methods. (2009). Clin Trials, 6(2):162-171. [15M01] [PMC2878478] [PMID: 19342469]
49. WE Whitehead, L Borrud, PS Goode, S Meikle, ER Mueller, A Tuteja, A Weidner, M Weinstein & W Ye, for the Pelvic Floor Disorders Network. Fecal incontinence in US adults: epidemiology and risk factors. (2009). Gastroenterology, 137(2):512-517, 517 e511-512. [NHANES-FI] [PMC2748224] [PMID: 19410574]
50. MD Barber, C Spino, NK Janz, L Brubaker, I Nygaard, CW Nager & TL Wheeler, for the Pelvic Floor Disorders Network. The minimum important differences for the urinary scales of the Pelvic Floor Distress Inventory and Pelvic Floor Impact Questionnaire. (2009). Am J Obstet Gynecol, 200(5):580 e581-587. [13A02] [PMC2680021] [PMID: 19375574]
51. L Hoyte, L Brubaker, JR Fielding, ME Lockhart, ME Heilbrun, CG Salomon, W Ye & MB Brown, for the Pelvic Floor Disorders Network. Measurements from image-based three dimensional pelvic floor reconstruction: a study of inter- and intraobserver reliability. (2009). J Magn Reson Imaging, 30(2):344-350. [2A11M] [PMC2882153] [PMID: 19629987]
52. VL Handa, I Nygaard, K Kenton, GW Cundiff, C Ghetti, W Ye & HE Richter, for the Pelvic Floor Disorders Network. Pelvic organ support among primiparous women in the first year after childbirth. (2009). Int Urogynecol J Pelvic Floor Dysfunct, 20(12):1407-1411. [2A15] [PMCID Needed] [PMID: 19777148]
53. MD Barber, L Brubaker, I Nygaard, TL Wheeler, 2nd, J Schaffer, Z Chen & C Spino, for the Pelvic Floor Disorders Network. Defining success after surgery for pelvic organ prolapse. (2009). Obstet Gynecol, 114(3):600-609. [1A24] [PMC2904469] [PMID: 19701041]
54. CW Nager, HE Richter, I Nygaard, MF Paraiso, JM Wu, K Kenton, SD Atnip & C Spino, for the Pelvic Floor Disorders Network. Incontinence pessaries: size, POPQ measures, and successful fitting. (2009). Int Urogynecol J Pelvic Floor Dysfunct, 20(9):1023-1028. [13A04] [PMC2721123] [PMID: 19533009]
55. CS Bradley, DD Rahn, IE Nygaard, MD Barber, CW Nager, KS Kenton, NY Siddiqui, RB Abel, C Spino & HE Richter, The Questionnaire for Urinary Incontinence Diagnosis (QUID): validity and responsiveness to change in women undergoing non-surgical therapies for treatment of stress predominant urinary incontinence. (2009). Neurourol Urodyn, [13A05] [PMC2891326] [PMID: 19787711]
56. ME Heilbrun, IE Nygaard, ME Lockhart, HE Richter, MB Brown, KS Kenton, DD Rahn, JV Thomas, AC Weidner, CW Nager & JO Delancey, Correlation between levator ani muscle injuries on magnetic resonance imaging and fecal incontinence, pelvic organ prolapse, and urinary incontinence in primiparous women. (2010). Am J Obstet Gynecol, 202(5):488 e481-486. [2A21] [PMC2866791] [PMID: 20223445]
57. HE Richter, KL Burgio, L Brubaker, IE Nygaard, W Ye, A Weidner, CS Bradley, VL Handa, D Borello-France, PS Goode, H Zyczynski, ES Lukacz, J Schaffer, M Barber, S Meikle & C Spino, for the Pelvic Floor Disorders Network. Continence pessary compared with behavioral therapy or combined therapy for stress incontinence: a randomized controlled trial. (2010). Obstet Gynecol, 115(3):609-617. [13P01a] [PMC2914312] [PMID: 20177294]
58. RE Gutman, CS Bradley, W Ye, AD Markland, WE Whitehead & MP Fitzgerald, for the Pelvic Floor Disorders Network. Effects of colpocleisis on bowel symptoms among women with severe pelvic organ prolapse. (2010). Int Urogynecol J Pelvic Floor Dysfunct, 21(4):461-466. [7A01] [PMC2896064] [PMID: 19960182]
59. L Brubaker, MD Barber, I Nygaard, CW Nager, E Varner, J Schaffer, A Visco, S Meikle & C Spino, for the Pelvic Floor Disorders Network. Quantification of vaginal support: are continuous summary scores better than POPQ stage? (2010). Am J Obstet Gynecol, [1A27] [PMC2975822] [PMID: 20728072]
60. VL Handa, E Whitcomb, AC Weidner, I Nygaard, L Brubaker, CS Bradley, MF Paraiso, J Schaffer, HM Zyczynski, M Zhang & HE Richter, Sexual function before and after non-surgical treatment for stress urinary incontinence. (2011). Female Pelvic Med Reconstr Surg, 17(1):30-35. [13P01c] [PMC3092501] [PMID: 21572534]
61. L Hoyte, W Ye, L Brubaker, JR Fielding, ME Lockhart, ME Heilbrun, MB Brown & SK Warfield, for the Pelvic Floors Disorders Network. Segmentations of MRI images of the female pelvic floor: a study of inter- and intra-reader reliability. (2011). J Magn Reson Imaging, 33(3):684-691. [2A11C/CREATE] [PMCID Needed] [PMID: 21563253]
62. MD Barber, Z Chen, E Lukacz, A Markland, C Wai, L Brubaker, I Nygaard, A Weidner, NK Janz & C Spino, Further validation of the short form versions of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ). (2011). Neurourol Urodyn, 30(4):541-546. [X01] [PMCID Needed] [PMID: 21344495]

1. Bessho K, Mourya R, Shivakumar P, Walters S, Magee JC, Rao M, et al. Gene expression signature for biliary atresia and a role for interleukin-8 in pathogenesis of experimental disease. Hepatology (Baltimore, Md). 2014;60(1):211-23.
2. Bezerra JA, Spino C, Magee JC, Shneider BL, Rosenthal P, Wang KS, et al. Use of corticosteroids after hepatoportoenterostomy for bile drainage in infants with biliary atresia: the START randomized clinical trial. Jama. 2014;311(17):1750-9.
3. DeRusso PA, Ye W, Shepherd R, Haber BA, Shneider BL, Whitington PF, et al. Growth failure and outcomes in infants with biliary atresia: a report from the Biliary Atresia Research Consortium. Hepatology (Baltimore, Md). 2007;46(5):1632-8.
4. Kamath BM, Chen Z, Romero R, Fredericks EM, Alonso EM, Arnon R, et al. Quality of Life and Its Determinants in a Multicenter Cohort of Children with Alagille Syndrome. The Journal of pediatrics. 2015;167(2):390-6.e3.
5. Kamath BM, Piccoli DA, Magee JC, Sokol RJ. Pancreatic insufficiency is not a prevalent problem in Alagille syndrome. Journal of pediatric gastroenterology and nutrition. 2012;55(5):612-4.
6. Leung DH, Ye W, Molleston JP, Weymann A, Ling S, Paranjape SM, et al. Baseline Ultrasound and Clinical Correlates in Children with Cystic Fibrosis. The Journal of pediatrics. 2015;167(4):862-8.e2.
7. Molleston JP, Sokol RJ, Karnsakul W, Miethke A, Horslen S, Magee JC, et al. Evaluation of the child with suspected mitochondrial liver disease. Journal of pediatric gastroenterology and nutrition. 2013;57(3):269-76.
8. Ng VL, Haber BH, Magee JC, Miethke A, Murray KF, Michail S, et al. Medical status of 219 children with biliary atresia surviving long-term with their native livers: results from a North American multicenter consortium. The Journal of pediatrics. 2014;165(3):539-46.e2.
9. Russo P, Magee JC, Boitnott J, Bove KE, Raghunathan T, Finegold M, et al. Design and validation of the biliary atresia research consortium histologic assessment system for cholestasis in infancy. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2011;9(4):357-62.e2.
10. Sambrotta M, Strautnieks S, Papouli E, Rushton P, Clark BE, Parry DA, et al. Mutations in TJP2 cause progressive cholestatic liver disease. Nature genetics. 2014;46(4):326-8.
11. Schwarz KB, Haber BH, Rosenthal P, Mack CL, Moore J, Bove K, et al. Extrahepatic anomalies in infants with biliary atresia: results of a large prospective North American multicenter study. Hepatology (Baltimore, Md). 2013;58(5):1724-31.
12. Shneider BL, Abel B, Haber B, Karpen SJ, Magee JC, Romero R, et al. Portal hypertension in children and young adults with biliary atresia. Journal of pediatric gastroenterology and nutrition. 2012;55(5):567-73.
13. Shneider BL, Brown MB, Haber B, Whitington PF, Schwarz K, Squires R, et al. A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000. The Journal of pediatrics. 2006;148(4):467-74.
14. Shneider BL, Magee JC, Bezerra JA, Haber B, Karpen SJ, Raghunathan T, et al. Efficacy of fat-soluble vitamin supplementation in infants with biliary atresia. Pediatrics. 2012;130(3):e607-14.
15. Shneider BL, Magee JC, Karpen SJ, Rand EB, Narkewicz MR, Bass LM, et al. Total Serum Bilirubin within 3 Months of Hepatoportoenterostomy Predicts Short-Term Outcomes in Biliary Atresia. The Journal of pediatrics. 2016;170:211-7.e2.
16. Sundaram SS, Alonso EM, Haber B, Magee JC, Fredericks E, Kamath B, et al. Health related quality of life in patients with biliary atresia surviving with their native liver. The Journal of pediatrics. 2013;163(4):1052-7.e2.
17. Superina R, Magee JC, Brandt ML, Healey PJ, Tiao G, Ryckman F, et al. The anatomic pattern of biliary atresia identified at time of Kasai hepatoportoenterostomy and early postoperative clearance of jaundice are significant predictors of transplant-free survival. Annals of surgery. 2011;254(4):577-85.
18. Teckman JH, Rosenthal P, Abel R, Bass LM, Michail S, Murray KF, et al. Baseline Analysis of a Young alpha-1-Antitrypsin Deficiency Liver Disease Cohort Reveals Frequent Portal Hypertension. Journal of pediatric gastroenterology and nutrition. 2015;61(1):94-101.
19. Tsai EA, Grochowski CM, Falsey AM, Rajagopalan R, Wendel D, Devoto M, et al. Heterozygous deletion of FOXA2 segregates with disease in a family with heterotaxy, panhypopituitarism, and biliary atresia. Human mutation. 2015;36(6):631-7.
20. Venkat VL, Shneider BL, Magee JC, Turmelle Y, Arnon R, Bezerra JA, et al. Total serum bilirubin predicts fat-soluble vitamin deficiency better than serum bile acids in infants with biliary atresia. Journal of pediatric gastroenterology and nutrition. 2014;59(6):702-7.
21. Wang H, Malone JP, Gilmore PE, Davis AE, Magee JC, Townsend RR, et al. Serum markers may distinguish biliary atresia from other forms of neonatal cholestasis. Journal of pediatric gastroenterology and nutrition. 2010;50(4):411-6.
22. Ye W, Rosenthal P, Magee JC, Whitington PF. Factors Determining delta-Bilirubin Levels in Infants With Biliary Atresia. Journal of pediatric gastroenterology and nutrition. 2015;60(5):659-63.
23. Zahm AM, Hand NJ, Boateng LA, Friedman JR. Circulating microRNA is a biomarker of biliary atresia. Journal of pediatric gastroenterology and nutrition. 2012;55(4):366-9.

1. Han SH, Reddy KR, Keeffe EB, Soldevila-Pico C, Gish R, Chung RT, Degertekin B, Lok A; NIH HBV OLT Study Group. Clinical outcomes of liver transplantation for HBV-related hepatocellular carcinoma: data from the NIH HBV OLT study. Clin Transplant. 2011 Mar-Apr;25(2):E152-62. doi: 10.1111/j.1399-0012.2010.01349.x. Epub 2010 Nov 16. PubMed PMID: 21077950; PubMed Central PMCID: PMC3771871.

2. Degertekin B, Han SH, Keeffe EB, Schiff ER, Luketic VA, Brown RS Jr, Emre S, Soldevila-Pico C, Reddy KR, Ishitani MB, Tran TT, Pruett TL, Lok AS; NIH HBV-OLT Study Group. Impact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantation. Am J Transplant. 2010 Aug;10(8):1823-33. doi: 10.1111/j.1600-6143.2010.03046.x. Epub 2010 Mar 23. PubMed PMID: 20346062; PubMed Central PMCID: PMC2910807.

3. Bzowej N, Han S, Degertekin B, Keeffe EB, Emre S, Brown R, Reddy R, Lok AS; National Institutes of Health Hepatitis B Virus Orthotopic Liver Transplantation Study Group. Liver transplantation outcomes among Caucasians, Asian Americans, and African Americans with hepatitis B. Liver Transpl. 2009 Sep;15(9):1010-20. doi: 10.1002/lt.21759. PubMed PMID: 19718627; PubMed Central PMCID: PMC4438268.

4. Ito K, Kim KH, Lok AS, Tong S. Characterization of genotype-specific carboxyl-terminal cleavage sites of hepatitis B virus e antigen precursor and identification of furin as the candidate enzyme. J Virol. 2009 Apr;83(8):3507-17. doi: 10.1128/JVI.02348-08. Epub 2009 Feb 4. PubMed PMID: 19193799; PubMed Central PMCID: PMC2663268.

5. Lok AS. How to diagnose and treat hepatitis B virus antiviral drug resistance in the liver transplant setting. Liver Transpl. 2008 Oct;14 Suppl 2:S8-S14. doi: 10.1002/lt.21616. Review. PubMed PMID: 18825720.

6. Gaglio P, Singh S, Degertekin B, Ishitani M, Hussain M, Perrillo R, Lok AS; National Institutes of Health Hepatitis B Virus-Orthotopic Liver Transplantation Study Group. Impact of the hepatitis B virus genotype on pre- and post-liver transplantation outcomes. Liver Transpl. 2008 Oct;14(10):1420-7. doi: 10.1002/lt.21563. PubMed PMID: 18825703.

7. Osborn MK, Han SH, Regev A, Bzowej NH, Ishitani MB, Tran TT, Lok AS; NIH HBV-OLT Study Group. Outcomes of patients with hepatitis B who developed antiviral resistance while on the liver transplant waiting list. Clin Gastroenterol Hepatol. 2007 Dec;5(12):1454-61. Epub 2007 Oct 31. PubMed PMID: 17977800; PubMed Central PMCID: PMC2645788.

8. Hussain M, Soldevila-Pico C, Emre S, Luketic V, Lok AS; NIH HBV-OLT Study Group. Presence of intrahepatic (total and ccc) HBV DNA is not predictive of HBV recurrence after liver transplantation. Liver Transpl. 2007 Aug;13(8):1137-44. PubMed PMID: 17663390.

9. Degertekin B, Lok AS. When to start and stop hepatitis B treatment: can one set of criteria apply to all patients regardless of age at infection? Ann Intern Med. 2007 Jul 3;147(1):62-4. PubMed PMID: 17606963.

10. Lok AS, Zoulim F, Locarnini S, Bartholomeusz A, Ghany MG, Pawlotsky JM, Liaw YF, Mizokami M, Kuiken C; Hepatitis B Virus Drug Resistance Working Group. Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management. Hepatology. 2007 Jul;46(1):254-65. Review. PubMed PMID: 17596850.

11. Lok AS. Navigating the maze of hepatitis B treatments. Gastroenterology. 2007 Apr;132(4):1586-94. Epub 2007 Feb 24. Review. Erratum in: Gastroenterology. 2007 Dec;133(6):2077. PubMed PMID: 17408643.

 

1. Riches DW, Burnham EL, Moss M, Downey GP, Schmidt EP. Introduction to the 57th annual Thomas L. Petty Aspen Lung Conference: Rebuilding the injured lung. Annals of the American Thoracic Society. 2015;12 Suppl 1:S1-2.
2. Kovach MA, Stringer KA, Bunting R, Wu X, San Mateo L, Newstead MW, et al. Microarray analysis identifies IL-1 receptor type 2 as a novel candidate biomarker in patients with acute respiratory distress syndrome. Respiratory research. 2015;16:29.
3. Evans CR, Karnovsky A, Kovach MA, Standiford TJ, Burant CF, Stringer KA. Untargeted LC-MS metabolomics of bronchoalveolar lavage fluid differentiates acute respiratory distress syndrome from health. Journal of proteome research. 2014;13(2):640-9.
4. Burnham EL, Janssen WJ, Riches DW, Moss M, Downey GP. The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance. The European respiratory journal. 2014;43(1):276-85.
5. Burnham EL, Hyzy RC, Paine R, 3rd, Kelly AM, Quint LE, Lynch D, et al. Detection of fibroproliferation by chest high-resolution CT scan in resolving ARDS. Chest. 2014;146(5):1196-204.
6. Thannickal VJ. Mechanistic links between aging and lung fibrosis. Biogerontology. 2013;14(6):609-15.
7. Finigan JH, Mishra R, Vasu VT, Silveira LJ, Nethery DE, Standiford TJ, et al. Bronchoalveolar lavage neuregulin-1 is elevated in acute lung injury and correlates with inflammation. The European respiratory journal. 2013;41(2):396-401.
8. Burnham EL, Hyzy RC, Paine R, 3rd, Coley C, 2nd, Kelly AM, Quint LE, et al. Chest CT features are associated with poorer quality of life in acute lung injury survivors. Critical care medicine. 2013;41(2):445-56.
9. Bosmann M, Grailer JJ, Ruemmler R, Russkamp NF, Zetoune FS, Sarma JV, et al. Extracellular histones are essential effectors of C5aR- and C5L2-mediated tissue damage and inflammation in acute lung injury. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2013;27(12):5010-21.
10. Paine R, 3rd, Standiford TJ, Dechert RE, Moss M, Martin GS, Rosenberg AL, et al. A randomized trial of recombinant human granulocyte-macrophage colony stimulating factor for patients with acute lung injury. Critical care medicine. 2012;40(1):90-7.
11. Stringer KA, Serkova NJ, Karnovsky A, Guire K, Paine R, 3rd, Standiford TJ. Metabolic consequences of sepsis-induced acute lung injury revealed by plasma (1)H-nuclear magnetic resonance quantitative metabolomics and computational analysis. American journal of physiology Lung cellular and molecular physiology. 2011;300(1):L4-l11.
12. Moss M, Standiford TJ. Leptin in fibroproliferative acute respiratory distress syndrome: not just a satiety factor. American journal of respiratory and critical care medicine. 2011;183(11):1443-4.
13. Kovach MA, Standiford TJ. Toll like receptors in diseases of the lung. International immunopharmacology. 2011;11(10):1399-406.
14. Deng JC, Standiford TJ. Growth factors and cytokines in acute lung injury. Comprehensive Physiology. 2011;1(1):81-104.
15. Ware LB, Koyama T, Billheimer DD, Wu W, Bernard GR, Thompson BT, et al. Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest. 2010;137(2):288-96.
16. Seki M, Kohno S, Newstead MW, Zeng X, Bhan U, Lukacs NW, et al. Critical role of IL-1 receptor-associated kinase-M in regulating chemokine-dependent deleterious inflammation in murine influenza pneumonia. Journal of immunology (Baltimore, Md : 1950). 2010;184(3):1410-8.
17. Reddy RC, Standiford TJ. Effects of sepsis on neutrophil chemotaxis. Current opinion in hematology. 2010;17(1):18-24.
18. Reddy RC, Standiford TJ. Nrf2 and PPAR{gamma}: PPARtnering against oxidant-induced lung injury. American journal of respiratory and critical care medicine. 2010;182(2):134-5.
19. Lyn-Kew K, Rich E, Zeng X, Wen H, Kunkel SL, Newstead MW, et al. IRAK-M regulates chromatin remodeling in lung macrophages during experimental sepsis. PloS one. 2010;5(6):e11145.
20. Hubbard LL, Ballinger MN, Thomas PE, Wilke CA, Standiford TJ, Kobayashi KS, et al. A role for IL-1 receptor-associated kinase-M in prostaglandin E2-induced immunosuppression post-bone marrow transplantation. Journal of immunology (Baltimore, Md : 1950). 2010;184(11):6299-308.
21. Draganov D, Teiber J, Watson C, Bisgaier C, Nemzek J, Remick D, et al. PON1 and oxidative stress in human sepsis and an animal model of sepsis. Advances in experimental medicine and biology. 2010;660:89-97.
22. Bhan U, Ballinger MN, Zeng X, Newstead MJ, Cornicelli MD, Standiford TJ. Cooperative interactions between TLR4 and TLR9 regulate interleukin 23 and 17 production in a murine model of gram negative bacterial pneumonia. PloS one. 2010;5(3):e9896.
23. Thannickal VJ. Oxygen in the evolution of complex life and the price we pay. American journal of respiratory cell and molecular biology. 2009;40(5):507-10.
24. Ito T, Schaller M, Hogaboam CM, Standiford TJ, Sandor M, Lukacs NW, et al. TLR9 regulates the mycobacteria-elicited pulmonary granulomatous immune response in mice through DC-derived Notch ligand delta-like 4. The Journal of clinical investigation. 2009;119(1):33-46.
25. Wen H, Schaller MA, Dou Y, Hogaboam CM, Kunkel SL. Dendritic cells at the interface of innate and acquired immunity: the role for epigenetic changes. Journal of leukocyte biology. 2008;83(3):439-46.
26. Wen H, Dou Y, Hogaboam CM, Kunkel SL. Epigenetic regulation of dendritic cell-derived interleukin-12 facilitates immunosuppression after a severe innate immune response. Blood. 2008;111(4):1797-804.
27. Reddy RC, Narala VR, Keshamouni VG, Milam JE, Newstead MW, Standiford TJ. Sepsis-induced inhibition of neutrophil chemotaxis is mediated by activation of peroxisome proliferator-activated receptor-{gamma}. Blood. 2008;112(10):4250-8.
28. Milam JE, Keshamouni VG, Phan SH, Hu B, Gangireddy SR, Hogaboam CM, et al. PPAR-gamma agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis. American journal of physiology Lung cellular and molecular physiology. 2008;294(5):L891-901.
29. Ishii M, Hogaboam CM, Joshi A, Ito T, Fong DJ, Kunkel SL. CC chemokine receptor 4 modulates Toll-like receptor 9-mediated innate immunity and signaling. European journal of immunology. 2008;38(8):2290-302.
30. Horowitz JC, Rogers DS, Simon RH, Sisson TH, Thannickal VJ. Plasminogen activation induced pericellular fibronectin proteolysis promotes fibroblast apoptosis. American journal of respiratory cell and molecular biology. 2008;38(1):78-87.
31. Garneau-Tsodikova S, Thannickal VJ. Protein kinase inhibitors in the treatment of pulmonary fibrosis. Current medicinal chemistry. 2008;15(25):2632-40.
32. Wen H, Hogaboam CM, Lukacs NW, Cook DN, Lira SA, Kunkel SL. The chemokine receptor CCR6 is an important component of the innate immune response. European journal of immunology. 2007;37(9):2487-98.
33. Vittal R, Zhang H, Han MK, Moore BB, Horowitz JC, Thannickal VJ. Effects of the protein kinase inhibitor, imatinib mesylate, on epithelial/mesenchymal phenotypes: implications for treatment of fibrotic diseases. The Journal of pharmacology and experimental therapeutics. 2007;321(1):35-44.
34. Thomas PE, Peters-Golden M, White ES, Thannickal VJ, Moore BB. PGE(2) inhibition of TGF-beta1-induced myofibroblast differentiation is Smad-independent but involves cell shape and adhesion-dependent signaling. American journal of physiology Lung cellular and molecular physiology. 2007;293(2):L417-28.
35. Raymond T, Schaller M, Hogaboam CM, Lukacs NW, Rochford R, Kunkel SL. Toll-like receptors, Notch ligands, and cytokines drive the chronicity of lung inflammation. Proceedings of the American Thoracic Society. 2007;4(8):635-41.
36. Lama VN, Smith L, Badri L, Flint A, Andrei AC, Murray S, et al. Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts. The Journal of clinical investigation. 2007;117(4):989-96.
37. Ito T, Schaller M, Hogaboam CM, Standiford TJ, Chensue SW, Kunkel SL. TLR9 activation is a key event for the maintenance of a mycobacterial antigen-elicited pulmonary granulomatous response. European journal of immunology. 2007;37(10):2847-55.
38. Horowitz JC, Rogers DS, Sharma V, Vittal R, White ES, Cui Z, et al. Combinatorial activation of FAK and AKT by transforming growth factor-beta1 confers an anoikis-resistant phenotype to myofibroblasts. Cellular signalling. 2007;19(4):761-71.
39. Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, Gabbiani G. The myofibroblast: one function, multiple origins. The American journal of pathology. 2007;170(6):1807-16.
40. Gharaee-Kermani M, Hu B, Thannickal VJ, Phan SH, Gyetko MR. Current and emerging drugs for idiopathic pulmonary fibrosis. Expert opinion on emerging drugs. 2007;12(4):627-46.

1. Tayob N, Murray S. Nonparametric restricted mean analysis across multiple follow-up intervals. Statistics & probability letters. 2016;109:152-8.
2. Suissa S, Ernst P. The INPULSIS enigma: exacerbations in idiopathic pulmonary fibrosis. Thorax. 2015;70(5):508-10.
3. Murray LA, Zhang H, Oak SR, Coelho AL, Herath A, Flaherty KR, et al. Targeting interleukin-13 with tralokinumab attenuates lung fibrosis and epithelial damage in a humanized SCID idiopathic pulmonary fibrosis model. American journal of respiratory cell and molecular biology. 2014;50(5):985-94.
4. Huang LS, Mathew B, Li H, Zhao Y, Ma SF, Noth I, et al. The mitochondrial cardiolipin remodeling enzyme lysocardiolipin acyltransferase is a novel target in pulmonary fibrosis. American journal of respiratory and critical care medicine. 2014;189(11):1402-15.
5. Han MK, Zhou Y, Murray S, Tayob N, Noth I, Lama VN, et al. Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study. The Lancet Respiratory medicine. 2014;2(7):548-56.
6. Flaherty KR, Khanna D. Idiopathic or connective tissue disease-associated interstitial lung disease: a case of HRCT mimicry. Thorax. 2014;69(3):205-6.
7. Blackwell TS, Tager AM, Borok Z, Moore BB, Schwartz DA, Anstrom KJ, et al. Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report. American journal of respiratory and critical care medicine. 2014;189(2):214-22.
8. Noth I, Zhang Y, Ma SF, Flores C, Barber M, Huang Y, et al. Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study. The Lancet Respiratory medicine. 2013;1(4):309-17.
9. Herazo-Maya JD, Noth I, Duncan SR, Kim S, Ma SF, Tseng GC, et al. Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosis. Science translational medicine. 2013;5(205):205ra136.
10. B BM, Lawson WE, Oury TD, Sisson TH, Raghavendran K, Hogaboam CM. Animal models of fibrotic lung disease. American journal of respiratory cell and molecular biology. 2013;49(2):167-79.
11. Zhou T, Zhang W, Sweiss NJ, Chen ES, Moller DR, Knox KS, et al. Peripheral blood gene expression as a novel genomic biomarker in complicated sarcoidosis. PloS one. 2012;7(9):e44818.
12. Vij R, Noth I. Peripheral blood biomarkers in idiopathic pulmonary fibrosis. Translational research : the journal of laboratory and clinical medicine. 2012;159(4):218-27.
13. White ES, Muro AF. Fibronectin splice variants: understanding their multiple roles in health and disease using engineered mouse models. IUBMB life. 2011;63(7):538-46.

 
1. Gorelik GJ, Yarlagadda S, Patel DR, Richardson BC. Protein kinase Cδ oxidation contributes to ERK inactivation in lupus T cells. Arthritis Rheum. 2012 Sep;64(9):2964-74. PMCID: PMC3414679

1. Saluja I, Paulson H, Gupta A, Turner RS. X11alpha haploinsufficiency enhances Abeta amyloid deposition in Alzheimer's disease transgenic mice. Neurobiol Dis. 2009 Oct;36(1):162-8. PMCID: PMC2742573

1. Elmunzer BJ, Serrano J, Chak A, Edmundowicz SA, Papachristou GI, Scheiman JM, Singh VK, Varadurajulu S, Vargo JJ, Willingham FF, Baron TH, Coté GA, Romagnuolo J, Wood-Williams A, Depue EK, Spitzer RL, Spino C, Foster LD, Durkalski V; SVI study group and the United States Cooperative for Outcomes Research in Endoscopy (USCORE). Rectal indomethacin alone versus indomethacin and prophylactic pancreatic stent placement for preventing pancreatitis after ERCP: study protocol for a randomized controlled trial. Trials. 2016 Mar 3;17(1):120. PMCID: PMC4778337

1. Foxman B, Cronenwett AE, Spino C, Berger MB, Morgan DM. Cranberry juice capsules and urinary tract infection after surgery: results of a randomized trial. American journal of obstetrics and gynecology. 2015;213(2):194.e1-8.
2. Marschall J, Piccirillo ML, Foxman B, Zhang L, Warren DK, Henderson JP. Patient characteristics but not virulence factors discriminate between asymptomatic and symptomatic E. coli bacteriuria in the hospital. BMC infectious diseases. 2013;13:213.
3. Foxman B, Buxton M. Alternative approaches to conventional treatment of acute uncomplicated urinary tract infection in women. Current infectious disease reports. 2013;15(2):124-9.
4. Marschall J, Zhang L, Foxman B, Warren DK, Henderson JP. Both host and pathogen factors predispose to Escherichia coli urinary-source bacteremia in hospitalized patients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2012;54(12):1692-8.

1. Lewicky-Gaupp C, Hamilton Q, Ashton-Miller J, Huebner M, DeLancey JO, Fenner DE. Anal sphincter structure and function relationships in aging and fecal incontinence. Am J Obstet Gynecol. 2009 May;200(5):559.e1-5. PMID: 19136096

2. Lewicky-Gaupp C, Wei JT, Delancey JO, Fenner DE, McGuire EJ, Morgan DM. The association of Incontinence Symptom Index scores with urethral function and support. Am J Obstet Gynecol. 2008 Dec;199(6):680.e1-5. PMID: 18976736